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Introduction/aims
Using functional resonance imaging (fMRI) with a standar-
dized paradigm for trigemino-nociceptive stimulation [1],
we explored the effect of sumatriptan on central pain pro-
cessing structures compared to saline and acetylsalicylic
acid (ASA). Given the mode of action of triptans [2-4], we
hypothesized, that differences in BOLD activation between
sumatriptan and saline/ASA would be revealed in the
trigeminal nuclei.
Methods
We scanned 21 healthy volunteers for each group (suma-
triptan, ASA) at two different time points (within-subject
design). Differences in behavioural and imaging data
between medication and saline conditions as well as
between the medications were investigated. Using a
general psychophysiological interaction analysis (gPPI),
neuronal coupling between brain structures under saline
compared to sumatriptan condition were explored.
This double-blind fMRI study was approved by the
local Ethics Committee and all volunteers gave written
informed consent prior to fMRI data acquisition.
Results
Mean pain intensity ratings did not differ between saline
and sumatriptan/ASA conditions or between medications.
Imaging data reveals increased activation of the trigeminal
nuclei (T (18) = 3.59, p< 0.05 FWE corrected) after suma-
triptan compared to saline. The same was also true for
sumatriptan vs. ASA (T (31) = 2.8, p< 0.05, FWE cor-
rected). The gPPI showed an increased coupling between
the trigeminal nuclei and several cortical and subcortical
pain related brain areas for the saline condition during
painful stimulation.
Conclusion
The study reveals an increased activation within the tri-
geminal nuclei under sumatriptan treatment compared
to saline. Furthermore, this effect is specific for triptans.
As the coupling between the trigeminal nuclei and other
pain related brain structures during sumatriptan treat-
ment compared to saline is attenuated, we suggest a
weakening effect of sumatriptan on functional brain
connectivity during pain.
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